LOPERAMIDE HYDROCHL

The Defense Logistics Agency awarded a delivery order, SPE2DP-26-F-7541, to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 2.000 pharmaceutical units of LOPERAMIDE HYDROCHL, with National Stock Number 6505015495732, at a total value of $1.60. The order was issued on July 14, 2026, under the basic contract SPE2DX-25-D-9900 and requires delivery to Fort Drum, NY, by July 29, 2026, under FOB destination terms with payment responsibility falling to the contractor. The contractor is designated as a Small Business, Small Disadvantaged Business, and Women-Owned Business, and must comply with stringent shipping requirements, including the use of traceable transport methods and prohibition of parcel post. Packaging and marking must include the NSN, NDC, and identification numbers from the purchase order, with consignee information clearly labeled, though specific MIL-STDs are not cited. Invoicing is mandatory through the Wide Area WorkFlow system per DFARS 252.232-7003, and payment will be processed by the Defense Finance and Accounting Service at the designated remit-to address. Inspection and acceptance are the Government’s responsibility at the delivery site, and the contractor must ensure the product meets all contractual and regulatory standards. No contract clauses, evaluation factors, or detailed specifications were included in the order, with references pointing to the underlying basic contract for additional terms. The delivery quantity is fixed with no variance allowed, and medical substitution is permitted only with prior approval. The contracting officer is Lisa Quinn, reachable via DLA, and the issuing office is DLA Troop Support, Medical Supply Chain Pharm FSA.